Aethlon Medical Company Insiders

Aethlon Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.5479) % which means that it has lost $0.5479 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.9139) %, meaning that it created substantial loss on money invested by shareholders. Aethlon Medical's management efficiency ratios could be used to measure how well Aethlon Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of February 10, 2026, Return On Tangible Assets is expected to decline to -1.72. The current year's Return On Capital Employed is expected to grow to -1.87. At present, Aethlon Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 53.2 K, whereas Other Assets are forecasted to decline to 0.86. The current year's Common Stock Shares Outstanding is expected to grow to about 188.5 K, whereas Net Loss is forecasted to decline to (11.4 M). Aethlon Medical shows 3.19 percent of its outstanding shares held by insiders and 6.76 percent owned by other corporate entities. Some institutional investors establish a significant position in stocks such as Aethlon Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Aethlon Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Aethlon Medical Workforce Comparison

Aethlon Medical Insider Trading History

Aethlon Medical Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Aethlon Medical often depends on how effective the management is. Aethlon Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aethlon management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aethlon management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Aethlon Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aethlon Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Aethlon Medical's management manipulating its earnings.

When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.